subject area of

• 4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency  Academic Article
• A head-to-tail tandem organization of hsp70 genes in Trypanosoma-cruzi  Academic Article
• Acute Trypanosoma cruzi infection is associated with anemia, thrombocytopenia, leukopenia, and bone marrow hypoplasia: reversal by nifurtimox treatment  Academic Article
• Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51  Academic Article
• Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives  Academic Article
• Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway  Academic Article
• In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi  Academic Article
• Machine learning models and pathway genome data base for trypanosoma cruzi drug discovery  Academic Article
• Myocarditis, microbes and autoimmunity  Academic Article
• Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain  Academic Article
• Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents  Academic Article
• Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors  Academic Article
• Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase  Academic Article
• Synthesis of macrocyclic trypanosomal cysteine protease inhibitors  Academic Article
• The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs  Academic Article